Physician profile
Timothy J Byrne
NPI 1376585232
$613,522.31
in general payments reported to CMS, 2019-2025
22 companies · $176K in 2025
The $176K reported for 2025 was more than what 99% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142K · 2020: $75K · 2021: $57K · 2022: $45K · 2023: $58K · 2024: $60K · 2025: $176K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $134K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $131K · Food and Beverage: $16K · Consulting Fee: $11K · Honoraria: $2,750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $133,697.58 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $130,905.00 |
| Food and Beverage | $16,134.82 |
| Consulting Fee | $10,717.93 |
| Honoraria | $2,750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $372,302.28 | 2021-2025 | Apollotm, Corevalve Evolut R, Micra |
| Medtronic Vascular, INC. | $201,641.03 | 2019-2020 | |
| Abbott Laboratories | $24,316.68 | 2019-2025 | Mitraclip, Triclip, Amplatzer Amulet |
| Abiomed | $7,353.37 | 2020-2025 | Impella |
| Ancora Heart, INC. | $3,677.22 | 2023 | Accucinch |
| Edwards Lifesciences Corporation | $2,872.27 | 2020-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Cvrx, INC. | $539.44 | 2024-2025 | Barostim Neo System |
| Boston Scientific Corporation | $328.00 | 2020-2024 | Watchman Access System, Watchman Flx |
| Angiodynamics, INC. | $82.81 | 2023 | Auryon Laser System 100-120 Vac |
| Cleerly, INC. | $72.84 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Siemens Medical Solutions USA, INC. | $59.25 | 2020-2025 | Acuson Sc2000 Diagnostic Ultrasound System, Acuson Origin Diagnostic Ultrasound System |
| Terumo Medical Corporation | $50.58 | 2023 | Glidesheath Slender |
| Bardy Diagnostics, INC. | $40.00 | 2019-2022 | |
| Biosense Webster, INC. | $33.87 | 2024 | Nuvision Ice Catheter |
| Novartis Pharmaceuticals Corporation | $27.57 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $26.56 | 2019 | |
| Zoll Respicardia, INC. | $22.31 | 2025 | Remede System |
| Argon Medical Devices, INC. | $20.29 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.24 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals Lp | $13.89 | 2022 | |
| Gilead Sciences, INC. | $12.80 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Byrne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.